This corresponds with the results of the previous studies showing high frequency of KRAS mutation in DNA isolated from blood of patients with NSCLC bearing this mutation (Kordiak et al. 2012; Ramirez et al. 2003). This evidence concerns the gene KRAS and non-small cell lung carcinoma.